Wesley Farris

Brigham and Women's Hospital

Papers

1

Total Citations

113

H-Index

1

About

Wesley Farris is a leading researcher in the molecular mechanisms of Alzheimer’s disease, with a primary focus on the proteolytic degradation of the amyloid β-protein (Aβ). His major contributions center on developing innovative biochemical tools to study how proteases regulate Aβ levels in the brain—a critical factor in both healthy aging and Alzheimer’s pathology. In his highly cited 2003 work (113 citations), Farris introduced novel fluorescence- and fluorescence polarization-based assays using a custom substrate to quantify Aβ degradation kinetics with unprecedented precision. This methodological breakthrough provided the field with robust, practical tools for investigating the enzymes that clear Aβ, opening new avenues for understanding disease progression and identifying therapeutic targets. His work has been instrumental in shifting focus toward Aβ clearance mechanisms as key determinants of Alzheimer’s risk. Farris’s research continues to influence studies on protease activity, peptide homeostasis, and neurodegeneration, making him a pivotal figure in the biochemistry of Alzheimer’s disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
113
Total Citations
113
Avg Citations/Paper
🏆 Most Cited Paper
Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays
113 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago